Insider Transactions in Q3 2025 at Agios Pharmaceuticals, Inc. (AGIO)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 10
2025
|
David Scadden Director |
SELL
Open market or private sale
|
Direct |
1,400
-7.37%
|
$56,000
$40.0 P/Share
|
|
Jul 10
2025
|
David Scadden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,400
+6.86%
|
$25,200
$18.09 P/Share
|
|
Jul 09
2025
|
Sarah Gheuens Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
11,914
-8.24%
|
$452,732
$38.34 P/Share
|
|
Jul 09
2025
|
Sarah Gheuens Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,914
+14.0%
|
$297,850
$25.01 P/Share
|
|
Jul 01
2025
|
Sarah Gheuens Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,091
-6.26%
|
$139,094
$34.17 P/Share
|
|
Jul 01
2025
|
Sarah Gheuens Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,374
+11.36%
|
-
|